FundedIQ
Biotechnology

Tympanogen, Inc.: Funding, Investors & Team (Sep 2026)

Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.

www.tympanogen.com LinkedIn Richmond, United States 1-10 employees
Total raised
$700k
Rounds
2
Latest
Undisclosed round
Apr 2022

Tympanogen, Inc. has raised $700k across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2022.

Tympanogen, Inc. Company Profile and Key Stats

Total funding raised
$700k
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
Apr 2022
Employees
1-10
reported band
Headquarters
Richmond, United States

Latest funding round on record: Apr 2022.

Tympanogen, Inc. Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Grant
$700k

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Tympanogen, Inc. raised $700k in a Grant announced in Nov 2021.

5 months later, an undisclosed round was announced in Apr 2022 with no disclosed amount.

Tympanogen, Inc. Founders and Leadership Team

Name
Role
Contact
Elaine Horn-Ranney
CEO
Locked

Contact details for the Tympanogen, Inc. team: 1 of 1 has an email address on file.

Start 14-day free trial →

Tympanogen, Inc. Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Funded Startups Like Tympanogen, Inc. in Biotechnology and Richmond

Companies Similar to Tympanogen, Inc.

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Tympanogen, Inc. Funding FAQs

What does Tympanogen, Inc. do?

Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.

How much funding has Tympanogen, Inc. raised?

Tympanogen, Inc. has raised $700k across 2 rounds on record.

When did Tympanogen, Inc. last raise funding?

Tympanogen, Inc.'s most recent funding round on record was announced in Apr 2022. The amount was not disclosed.

Who is the CEO of Tympanogen, Inc.?

Elaine Horn-Ranney is listed as CEO at Tympanogen, Inc..

Where is Tympanogen, Inc. headquartered?

Tympanogen, Inc. is based in Richmond, Virginia, United States.

How many employees does Tympanogen, Inc. have?

Tympanogen, Inc. is in the 1-10 employee band.

About FundedIQ's Tympanogen, Inc. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tympanogen, Inc. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.